Group 1 - Shenjian Co., Ltd. reported a net profit of 33.65 million yuan for 2024, a year-on-year increase of 32.29%, with a proposed cash dividend of 0.5 yuan per 10 shares [1] - Jingce Electronics experienced a net loss of 97.60 million yuan in 2024, transitioning from profit to loss, despite a revenue increase of 5.59% to 2.565 billion yuan [1] - Jingwei Co., Ltd. reported a net profit of 35.54 million yuan for 2024, a decrease of 36.76%, with a proposed cash dividend of 1.00 yuan per 10 shares [1][2] Group 2 - Minsheng Health achieved a net profit of 91.83 million yuan in 2024, a year-on-year increase of 7.24%, with a proposed cash dividend of 1.00 yuan per 10 shares [2] - Zhongshe Co., Ltd. reported a net profit of 10.16 million yuan for 2024, a decline of 76.24%, with a proposed cash dividend of 0.2 yuan per 10 shares [3] - Keyuan Smart reported a net profit of 252 million yuan for 2024, a year-on-year increase of 56.64%, with a proposed cash dividend of 0.4 yuan per 10 shares [4] Group 3 - Beilu Pharmaceutical reported a net profit of 14.54 million yuan for Q1 2025, a year-on-year increase of 26.13%, with revenue of 283 million yuan [5] - Wangsu Technology achieved a net profit of 192 million yuan for Q1 2025, a year-on-year increase of 38.54%, with revenue of 1.235 billion yuan [6] - Keyuan Pharmaceutical reported a net profit of 23.08 million yuan for Q1 2025, a year-on-year increase of 7.25%, despite a revenue decline of 23.98% [7] Group 4 - Guangting Information reported a net profit of 24.03 million yuan for Q1 2025, turning from loss to profit, with revenue of 134 million yuan [9] - Zhaori Technology reported a net loss of 1.23 million yuan for Q1 2025, with revenue of 35.23 million yuan [11] - Huakai Yibai reported a net loss of 15.09 million yuan for Q1 2025, despite revenue growth of 35.08% to 2.292 billion yuan [13] Group 5 - Xinhongye reported a net profit of 34.43 million yuan for Q1 2025, a year-on-year increase of 20.43%, with revenue of 755 million yuan [15] - Huning Co., Ltd. reported a net profit of 3.61 million yuan for Q1 2025, a year-on-year decrease of 45.68%, with revenue of 64.51 million yuan [16] - Camel Co., Ltd. reported a net profit of 237 million yuan for Q1 2025, a year-on-year increase of 51.89%, with revenue of 4.136 billion yuan [17] Group 6 - Hengtong Co., Ltd. reported a net profit of 42.55 million yuan for Q1 2025, a year-on-year increase of 51.62%, with revenue of 313 million yuan [19] - Changqing Technology reported a net profit of 35.38 million yuan for Q1 2025, a year-on-year decrease of 23.80%, with revenue of 246 million yuan [21] - Libaba Co., Ltd. reported a net profit of 34.72 million yuan for Q1 2025, a year-on-year increase of 9.91%, with revenue of 419 million yuan [22] Group 7 - Shouxiangu reported a net profit of 58.37 million yuan for Q1 2025, a year-on-year decrease of 24.32%, with revenue of 171 million yuan [24] - Bojun Technology announced a stock issuance application accepted by the Shenzhen Stock Exchange [24] - Dayou Energy announced the full resumption of production at its Gengcun coal mine, with an annual production capacity of 3.6 million tons [25] Group 8 - Deyang Co., Ltd. successfully acquired land use rights for industrial land in Ningbo for 45.80 million yuan [27] - Tianyu Pharmaceutical's subsidiary received a drug registration certificate for an injectable product [29] - Xingwang Yuda signed a strategic cooperation agreement with the Jilin Province Bionic Robot Innovation Center [30] Group 9 - Lifang Pharmaceutical received approval for clinical trials of a new drug [32] - Zai Sheng Technology reported a net profit of 33.56 million yuan for Q1 2025, a year-on-year increase of 3.69%, with revenue of 324 million yuan [34] - Jinxin Technology reported a net profit of 319,920 yuan for Q1 2025, turning from loss to profit, with revenue of 563 million yuan [36] Group 10 - Huayin Electric reported a net profit of 75.67 million yuan for Q1 2025, a year-on-year increase of 894.61%, with revenue of 2.307 billion yuan [37] - Xinghua Co., Ltd. reported a net loss of 95.51 million yuan for Q1 2025, with revenue of 840 million yuan [38] - Heren Technology reported a net loss of 384,410 yuan for Q1 2025, with revenue of 78.40 million yuan [40] Group 11 - Fenda Technology reported a net profit of 40.45 million yuan for Q1 2025, a year-on-year increase of 84.07%, with revenue of 760 million yuan [41] - Tongda Co., Ltd. reported a net profit of 25.49 million yuan for 2024, a year-on-year decrease of 69.15%, with revenue of 6.201 billion yuan [43] - Zhonghe Holdings reported a net profit of 283 million yuan for 2024, a year-on-year decrease of 54.69%, with a proposed cash dividend of 0.3 yuan per 10 shares [44] Group 12 - Jiantou Energy reported a net profit of 531 million yuan for 2024, a year-on-year increase of 181.59%, with a proposed cash dividend of 1.3 yuan per 10 shares [44] - Guanghua Technology reported a net loss of 205 million yuan for 2024, with revenue of 2.589 billion yuan [45] - Huajin Technology reported a net profit of 29.26 billion yuan for 2024, a year-on-year increase of 8.1%, with a proposed cash dividend of 9 yuan per 10 shares [46] Group 13 - Yingke Medical reported a net profit of 1.465 billion yuan for 2024, a year-on-year increase of 282.63%, with a proposed cash dividend of 1.00 yuan per 10 shares [46] - Solar Energy reported a net profit of 1.225 billion yuan for 2024, a year-on-year decrease of 22.38%, with a proposed cash dividend of 0.56 yuan per 10 shares [46] - Dongfang Electric reported a net profit of 318 million yuan for 2024, a year-on-year decrease of 50.62%, with a proposed cash dividend of 0.32 yuan per 10 shares [47] Group 14 - Tianneng Heavy Industry reported a net loss of 262 million yuan for 2024, with revenue of 3.273 billion yuan [48] - Gangyan High-tech reported a net profit of 249 million yuan for 2024, a year-on-year decrease of 22.08%, with a proposed cash dividend of 1.00 yuan per 10 shares [48] - Shihua Machinery reported a net profit of 96.88 million yuan for 2024, a year-on-year increase of 5.35%, with revenue of 8.037 billion yuan [49] Group 15 - Gongtong Pharmaceutical reported a net loss of 27.59 million yuan for 2024, with revenue of 537 million yuan [51] - Zhongjing Electronics reported a net loss of 87.43 million yuan for 2024, with revenue of 2.932 billion yuan [53] - Yudai Development reported a net loss of 114 million yuan for 2024, with revenue of 388 million yuan [55] Group 16 - Zhenhua Technology reported a net profit of 970 million yuan for 2024, a year-on-year decrease of 63.83%, with a proposed cash dividend of 1.8 yuan per 10 shares [56] - Jierong Technology reported a net loss of 298 million yuan for 2024, with revenue of 1.357 billion yuan [58] - Changgao Electric New reported a net profit of 252 million yuan for 2024, a year-on-year increase of 45.66%, with a proposed cash dividend of 0.8 yuan per 10 shares [60] Group 17 - Shibao Detection announced a plan to acquire 81% of Zhonghuan Lianshu for 52.65 million yuan [61] - Jiangsu Boyun announced a plan to reduce its shareholding by up to 3% [62] - Jingfeng Mingyuan announced a plan to acquire 100% of Yichong Technology for 3.283 billion yuan [63]

2025 年一季度报告披露提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 证券代码：300592 证券简称： 华凯易佰 公告编号：2025-039 华凯易佰科技股份有限公司 特此公告。 华凯易佰科技股份有限公司董事会 2025 年 4 月 25 日 华凯易佰科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日分别 召开了第四届董事会第八次会议、第四届监事会第八次会议，审议通过了《关于 公司 2025 年一季度报告的议案》。 为使投资者全面了解公司经营成果、财务状况，公司《2024 年一季度报告》 将于 2025 年 4 月 25 日刊登在中国证监会指定的创业板信息披露网站巨潮资讯网 （http://www.cninfo.com.cn），敬请投资者注意查阅。 ...

西部证券股份有限公司 独立财务顾问声明 西部证券股份有限公司作为华凯易佰科技股份有限公司重大资产购买的独 立财务顾问，根据《上市公司重大资产重组管理办法》《上市公司并购重组财务 顾问业务管理办法》等法律法规的有关规定，按照证券行业公认的业务标准、道 德规范，本着诚实信用、勤勉尽责的态度，经过审慎核查，结合上市公司 2024 年度报告，出具关于上市公司重大资产购买的持续督导意见。 本持续督导意见所依据的文件和材料由交易各方提供。本次交易各方保证其 所提供的有关本次重组的相关信息真实、准确和完整，没有虚假记载、误导性陈 述或者重大遗漏，并对所提供信息的真实性、准确性、完整性负责。 本独立财务顾问特别提醒投资者注意，本持续督导意见不构成对上市公司的 任何投资建议；投资者根据本持续督导意见所做出的任何投资决策而产生的相应 风险，本独立财务顾问不承担任何责任。 关于 华凯易佰科技股份有限公司 重大资产购买 之 2024 年度持续督导意见 独立财务顾问 二〇二五年四月 本独立财务顾问未委托或授权其他任何机构或个人提供未在本持续督导意 见中列载的信息和对本持续督导意见做任何解释或者说明。 本独立财务顾问提请投资者认真阅读上 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥2,291,894,216.24, representing a year-over-year increase of 35.08% compared to ¥1,696,741,014.32 in the same period last year[5]. - The net profit attributable to shareholders was -¥15,093,381.90, a decline of 118.42% from a profit of ¥81,948,947.54 in the previous year[5]. - The net cash flow from operating activities significantly increased by 505.25%, amounting to ¥81,914,704.59, compared to ¥13,534,116.03 in the same period last year[5]. - Total operating revenue for the current period reached ¥2,291,894,216.24, a significant increase from ¥1,696,741,014.32 in the previous period, representing a growth of approximately 35%[29]. - The net profit for the current period was a loss of ¥16,030,883.11, compared to a net profit of ¥81,948,947.54 in the previous period, reflecting a decline in profitability[30]. - The company reported a basic earnings per share of -0.0373, down from 0.2834 in the previous period[30]. Assets and Liabilities - The company's total assets decreased by 3.64% to ¥4,287,083,156.46 from ¥4,449,100,829.81 at the end of the previous year[5]. - Total assets decreased to ¥4,287,083,156.46 from ¥4,449,100,829.81, a reduction of approximately 3.6%[28]. - Total liabilities decreased to ¥1,901,025,930.73 from ¥2,071,999,796.51, showing a decline of about 8.2%[28]. - The company’s total non-current assets increased to ¥1,562,495,051.15 from ¥1,527,178,744.77, reflecting a growth of about 2.3%[28]. - The company reported total current assets of RMB 2.72 billion, down from RMB 2.92 billion at the beginning of the period[26]. Cash Flow - Cash flow from operating activities was ¥2,192,118,683.91, compared to ¥1,706,638,322.27 in the previous period, indicating an increase of approximately 28.5%[31]. - Operating cash inflow totaled ¥2,218,936,016.02, an increase from ¥1,724,562,602.73 year-over-year[32]. - Operating cash outflow amounted to ¥2,137,021,311.43, compared to ¥1,711,028,486.70 in the previous year[32]. - Cash flow from investment activities showed a net outflow of ¥36,063,661.07, improving from a net outflow of ¥92,387,273.36[32]. - Cash flow from financing activities resulted in a net inflow of ¥2,324,917.03, compared to a substantial inflow of ¥162,283,416.23 in the prior year[32]. - The ending balance of cash and cash equivalents was ¥447,733,965.99, down from ¥588,137,032.35 at the beginning of the period[33]. - The company received ¥54,500,000.00 from investment recoveries, a decrease from ¥329,000,000.00 in the previous year[32]. - Total cash inflow from financing activities was ¥17,479,285.08, compared to ¥164,210,049.82 last year[32]. - The company paid ¥4,491,141.31 in dividends and interest, up from ¥1,680,972.22 year-over-year[32]. - The impact of exchange rate changes on cash and cash equivalents was an increase of ¥9,442,109.90, compared to ¥6,861,428.67 previously[32]. Inventory Management - Inventory levels decreased by 18% compared to the end of 2024, indicating improved inventory management[9]. - The company implemented a stock clearance plan to optimize inventory structure, which contributed to improved cash flow[8]. - The gross profit margin faced short-term pressure due to promotional activities aimed at accelerating inventory turnover[9]. - Inventory decreased significantly to RMB 1.49 billion from RMB 1.82 billion, reflecting a reduction in stock levels[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 19,509[15]. - The largest shareholder, Mangliduo, holds 10.35% of shares, totaling 41,914,647 shares[15]. - The second-largest shareholder, Chaoran Mailun, holds 7.69% of shares, totaling 31,113,232 shares, with 12,350,000 shares pledged[15]. - The third-largest shareholder, Zhuang Juncho, holds 7.25% of shares, totaling 29,357,800 shares, with 22,018,350 shares under lock-up[15]. - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity[16]. - There are no changes in the number of preferred shareholders or any new restrictions on shares during the reporting period[17]. - The company has a total of 22,018,350 shares under lock-up due to executive restrictions[18]. - The company plans to allow the release of some restricted shares in 2024, subject to specific conditions[18]. - The top shareholders are closely related, with significant ownership stakes held by family members and associates[16]. - No changes were reported in the financing and securities lending activities of the top shareholders[16]. Incentive Plans and Future Plans - The company approved a stock incentive plan for 2024, with restricted stock vesting periods of 12, 24, and 36 months[19]. - The total amount of restricted stock granted under the incentive plan is 77,412,513 shares, with 58,149,255 shares subject to restrictions[20]. - The company plans to sell 44% of its stake in Shenzhen Huayi Xinda Investment Co., Ltd. for a transaction price of RMB 3.5 million[21]. - The company intends to issue convertible bonds with a total fundraising target of up to RMB 775.65 million, with a face value of RMB 100 per bond and a six-year term[22]. - The company approved a share repurchase plan to buy back its A-shares for employee stock ownership plans and stock incentives[23].

华凯易佰（300592）公告，2025年第一季度营业收入22.92亿元，同比增长35.08%。净亏损1509.34万 元，去年同期净利润8194.89万元。 ...

证券代码：300592 证券简称：华凯易佰 公告编号：2025-021 一、重要提示 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者 应当到证监会指定媒体仔细阅读年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 天健会计师事务所（特殊普通合伙）对本年度公司财务报告的审计意见为：标准的无保留意见。 本报告期会计师事务所变更情况：公司本年度会计师事务所未变更，为天健会计师事务所（特殊普通合 伙）。 非标准审计意见提示 □适用 √不适用 公司上市时未盈利且目前未实现盈利 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 公司经本次董事会审议通过的利润分配预案为：拟以公司现有总股本404,845,869股扣除公司拟回购注销 的股权激励限售股484,400股后的404,361,469股为基数，向全体股东每10股派发现金红利0.5元（含 税），送红股0股，以资本公积金向全体股东每10股转增0股。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 （一）公司简介 ■ （二）报告期主要业务或产品简介 1、 ...

1、股东大会届次：2024 年年度股东大会 2、股东大会的召集人：公司第四届董事会 证券代码：300592 证券简称：华凯易佰 公告编号：2025-038 华凯易佰科技股份有限公司 关于召开 2024 年年度股东大会通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 华凯易佰科技股份有限公司（以下简称"华凯易佰"或"公司"）于 2025 年 4 月 22 日召开第四届董事会第七次会议，审议通过了《关于提请公司召开 2024 年年度股东 大会的议案》，决定于 2025 年 5 月 16 日下午 14:30 在广东省深圳市龙岗区里浦街 7 号易佰网络公司会议室召开公司 2024 年年度股东大会。本次股东大会将采取现场投 票及网络投票的方式召开，现将本次股东大会的相关事项通知如下： 一、召开会议的基本情况 1 （2）网络投票：本次股东大会通过深圳证券交易所系统和互联网投票系统向全体股 东提供网络形式的投票平台，股权登记日登记在册的公司股东可以自网络投票时间内通 过上述系统形成表决权。 6、股权登记日：2025 年 5 月 12 日（星期一） 3、会议召开的合 ...

证券代码：300592 证券简称：华凯易佰 公告编号：2025-024 华凯易佰科技股份有限公司 第四届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、监事会会议召开情况 华凯易佰科技股份有限公司（以下简称"公司"）第四届监事会第七次会议于 2025 年 4 月 11 日以书面确认、微信及电话等方式通知至各位监事，会议于 2025 年 4 月 22 日下午 14：30 在湖南省长沙市岳麓区滨江路楷林国际 A 座 1610 公司 会议室以现场会议的方式召开。本次会议由公司监事会主席耿立鹏先生召集并主 持，会议应出席监事人数 3 人，实际出席监事人数 3 人，公司董事会秘书及证券 事务代表列席了会议。本次会议的召开和表决程序符合有关法律、法规和《公司 章程》的有关规定，会议形成的决议合法有效。 二、监事会会议审议情况 1、审议通过了《关于公司 2024 年度监事会工作报告的议案》； 经审议，2024 年度监事会工作报告客观、真实地反映了公司监事会 2024 年 度的各项工作。具体内容详见公司同日在巨潮资讯网（www.cninfo.co ...

证券代码：300592 证券简称：华凯易佰 公告编号：2025-023 华凯易佰科技股份有限公司 第四届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 华凯易佰科技股份有限公司（以下简称"公司"）第四届董事会第七次会议于 2025 年 4 月 11 日以微信、电话、书面确认等方式通知至各位董事，会议于 2025 年 4 月 22 日在湖南省长沙市岳麓区滨江路楷林国际 A 座 1610 公司会议室采取 现场会议方式召开。本次会议由公司董事长胡范金先生召集并主持，会议应出席 董事人数 9 人，实际出席董事人数 9 人，公司监事、高级管理人员列席了会议。 本次会议的召开和表决程序符合有关法律、法规和《公司章程》的有关规定，会 议形成的决议合法有效。 二、董事会会议审议情况 1、审议通过了《关于公司 2024 年度董事会工作报告的议案》； 经审议，2024 年度董事会工作报告客观、真实地反映了公司董事会 2024 年 度的各项工作。具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）上披 露的相关公告 ...

关于公司 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、审议程序 2025 年 4 月 22 日，公司召开第四届董事会第七次会议、第四届监事会第七 次会议，审议通过了《关于公司 2024 年度利润分配预案的议案》，本议案尚需 提交公司 2024 年年度股东大会审议。 二、利润分配预案的基本情况 1、本次利润分配方案分配基准为 2024 年度。 证券代码：300592 证券简称：华凯易佰 公告编号：2025-025 华凯易佰科技股份有限公司 公司最近三个会计年度累计现金分红金额为 135,888,321.85 元，高于最近三 个会计年度年均净利润的 30%，因此公司不触及《深圳证券交易所创业板股票上 市规则》第 9.4 条第（八）项规定的可能被实施其他风险警示情形。 2、按照《中华人民共和国公司法》（以下简称"《公司法》"）和《华凯 易佰科技股份有限公司章程》（以下简称"《公司章程》"）的规定，公司不存 在需要弥补亏损的情况。经天健会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报表实现归属于母公司所有者净利润为 ...